This publication includes IP covered under the following statements.

• This material contains content from LOINC . LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license . LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
  Show Usage
  • LOINC : VsEpiType and VsSectionCode
• This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org .
  Show Usage
  • SNOMED Clinical Terms® (SNOMED CT®): Bundle/bundle-epi-type3-example-wonderdrug , ClinicalUseDefinition/cud-contraindication-1 ... Show 8 more , ClinicalUseDefinition/cud-contraindication-2, ClinicalUseDefinition/cud-indication-1, ClinicalUseDefinition/cud-indication-2, ClinicalUseDefinition/cud-interaction-1, MedicationKnowledge/medication-knowledge-epi-type3-example, MedicationKnowledgeUvEpi, PatientCharacteristicType and VsRouteOfAdministration
• This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
  Show Usage
  • DoseAndRateType : Bundle/bundle-epi-type3-example-wonderdrug and MedicationKnowledge/medication-knowledge-epi-type3-example
• US government funded - content free to use by all
  Show Usage
  • NCI Thesaurus : VsPropertyColor , VsPropertyFlavor and VsPropertyShape
• Unless otherwise indicated, reproduction of material posted on Council of Europe websites, and reproduction of photographs for which the Council of Europe holds copyright – see legal notice \“photo credits\” – is authorised for private use and for informational and educational uses relating to the Council of Europe’s work. This authorisation is subject to the condition that the source be indicated and no charge made for reproduction. Persons wishing to make some other use than those specified above, including commercial use, of information and text posted on these sites are asked to apply for prior written authorisation to the Council of Europe, Directorate of Communication.
  Show Usage
  • EDQM Standard Terms : Bundle/bundle-epi-type2-example-blister-carton , Bundle/bundle-epi-type2-example-paracetamol ... Show 6 more , Bundle/bundle-epi-type3-example-wonderdrug, Ingredient/ingredient-epi-type2-example-blister-carton-active, Ingredient/ingredient-epi-type2-example-paracetamol-active, MedicationKnowledge/medication-knowledge-epi-type3-example, PackagedProductDefinition/ppd-epi-type2-example-blister-carton and PackagedProductDefinition/ppd-epi-type2-example-paracetamol
• WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.
  Show Usage
  • ATC classification system : VsAtcClassification